Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that men face an equal risk. Mayo Clinic experts say that men and women alike should be aware of thyroid ...
May 27, 2025
0
0
In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a study published in Cancer Discovery.
May 8, 2025
0
0
Telling the difference between benign and cancerous thyroid nodules before surgery is notoriously challenging, but a new study finds that a combination of artificial intelligence and data analysis techniques may yield surprisingly ...
May 6, 2025
0
0
A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, ...
Apr 29, 2025
0
0
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new research published in ...
Apr 25, 2025
0
0
Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns ...
Apr 25, 2025
0
0
An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving impressive accuracy exceeding ...
Apr 23, 2025
0
43
A new study led by researchers at Yale University published in Environmental Health Perspectives, suggests that early-life exposure to two widespread environmental pollutants—small particle air pollution and outdoor artificial ...
Apr 16, 2025
0
0
Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes & Endocrinology.
Feb 12, 2025
0
0
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a study published online ...
Jan 30, 2025
0
0
